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EDITORIAL
Photoacoustic mammography: 
prospects and promises
Breast cancer is the most frequently occur-
ring malignancy in women, and the lead-
ing cause of cancer death, with up to 
0.5 million mortalities in 2008 [1]. The 
strategy to reduce breast cancer deaths is 
by early detection, reliable diagnosis and 
effective treatments. The standard imag-
ing modality for breast cancer detection 
by screening asymptomatic women is x-ray 
imaging. Diagnosis is performed after the 
triple assessment of x-ray mammogra-
phy, ultrasonography and biopsy. MRI 
is used in specific problem-solving situa-
tions, such as when contradictory results 
are obtained from x-ray and ultrasound 
images. x-ray mammography is capable 
of producing 2D projection images with 
a high spatial resolution. However, x-ray 
mammo graphy, besides possessing ionizing 
hazards and requiring painful breast com-
pression, is less sensitive in dense breasts [2]. 
Ultrasonography is limited by poor soft tis-
sue contrast, inherent speckle noise, strong 
operator dependence and lack of stand-
ardization. Both x-ray mammography 
and ultrasound imaging focus on morpho-
logical changes in tissue, which are usually 
manifested in later progression of disease. 
MRI has high sensitivity, being capable 
of visualizing functional information of 
tumors, but suffers from variable specific-
ity, a relatively high cost and the need of 
a contrast agent, and excludes pregnant 
women, subjects with metal implants and 
claustrophobia [2]. Thus, there is a great 
need for an alternative nonionizing imag-
ing technique to detect and diagnose early 
stages of breast cancer with high sensitivity 
and specificity, but without  discomfort or 
the need of contrast agents.
Methods that can potentially address 
the limitations associated with conven-
tional imaging modalities are those that 
use light. The vascularization associated 
with cancer leads to an optical absorp-
tion contrast compared with healthy tis-
sue. Optical imaging with its nonionizing 
nature thus potentially has a high sensi-
tivity due to the rich optical absorption 
contrast and a high specificity due to the 
ability to perform spectroscopy. However, 
the resolution of optical mammography 
is poor due to strong light scattering in 
biological tissues. Photoacoustic (PA; also 
called optoacoustic) imaging addresses the 
resolution limitation of optical imaging 
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by allowing optical absorbing chromophores 
to emit ultrasound (US) waves. This occurs by 
thermal-elastic expansion at absorbing sites in 
response to short pulsed light excitation. Instead 
of detecting light, PA imaging detects US waves 
at the tissue surface. Since US scattering is con-
siderably lower than light scattering in tissue, PA 
imaging offers superior resolutions.
Thus, PA imaging combines the advantages 
from optical imaging, namely a high vascular-
ization-driven optical absorption contrast from 
cancer, and the advantages from ultrasound 
imaging, namely a high resolution and a large 
imaging depth. Early studies have shown much 
promise in visualizing breast cancer [3–10].
The application of PA using near infrared 
(NIR) light excitation for breast imaging was 
introduced by Oraevsky [3] and Kruger [4]. 
Oraevsky et al. reported an early 2D imager 
called the laser optoacoustic imaging system 
(LOIS), and the first results were reported in 
2001 [6]. In 2004, Manohar et al. presented the 
Twente Photoacoustic Mammoscope (PAM), 
which produces 3D images in regions of inter-
est [5], and first experiences of NIR-PA imaging 
of breast cancer in human subjects were reported 
in 2007 [6]. In this work, in four of the five cases 
of malignancies studied, PAM images revealed 
regions possessing higher PA intensity than the 
surrounding background, which was attrib-
uted to tumor angiogenesis. In 2009, Oraevsky 
et al. presented results using an upgraded ver-
sion of their 2D imager (LOIS-64) imaging 
27 patients [7]. They were able to visualize 18 out 
of 20 malignant lesions. In 2012, the author’s 
group showed new results on 12 patients using 
PAM, corroborating the earlier studies and giv-
ing new insights. A significant finding was that 
PAM could successfully visualize malignancies 
with a superior imaging contrast to x-ray mam-
mography [8], and the contrast was found to be 
independent of fibroglandular breast density. In 
the same year, Kyoto University [9] performed 
clinical studies on 27 patients using a prototype 
system based on a detection geometry similar 
to PAM, and found 20 out of 27 breast cancer 
lesions to be visible. In 2013, the group of Kruger 
reported a dedicated 3D breast imager. They 
were able to visualize vasculature throughout the 
breast tissue, including close to the chest wall in 
eight breasts from four healthy volunteers [10].
While much still needs to be learned, the 
clinical case studies presented to date have been 
very promising, and with this there is impetus to 
improve the present imaging prototypes. Here we 
present our thoughts on the future directions of 
technological development of PA mammography.
Sensitive & faithful detection of 
ultrasound
Imaging at large depths (5+ cm), which is 
required in the breast, represents a great chal-
lenge mainly due to the strong light attenua-
tion in breast tissue, which causes low signal 
amplitudes to be produced. Furthermore, since 
the expected PA signals have broad frequency 
spectra ranging from tens of kHz to a few MHz, 
a broadband detector is required. Therefore, the 
challenge ahead lies in researching and develop-
ing sensitive and faithful ultrasound detectors, a 
necessity that requires advanced and optimized 
piezoelectric transducers, or altogether new 
ultrasound detectors based on optical means 
[11]. The authors’ group has developed a labo-
ratory prototype tomography system with an 
optimized piezoelectric ultrasound detector 
array possessing unprecedented sensitivity with 
tolerable bandwidth, which could pave the way 
for  sensitive detection of breast cancer [12–14].
Multispectral PA mammography
Multispectral optoacoustic (PA) tomography 
(MSOT) has been used to resolve chromophoric 
and fluorescent agents with molecular specificity 
[15]. This technique utilizes multispectral illumi-
nation to differentiate specific spectral signatures 
of chromophores or key reporter agents over the 
background tissue absorption by decomposing the 
spectral contributions of different photon-absorb-
ers. Multispectral PA mammography can benefit 
the differentiation of the abundance of specific 
tissue components in the breast and the quan-
tification of blood oxygen saturation, and thus 
improve the specificity. However, complex tissue 
structures in the breast could challenge the esti-
mation of light fluence distribution, a necessary 
knowledge used to quantify the optical absorp-
tion coefficients of different photon absorbers 
at distinct light wavelengths in MSOT. Various 
inversion algorithms have been formulated 
attempting to recover the absorption co efficient 
in an iterative framework. Here the error between 
the measurement and its computed counterpart 
calculated using assumed optical properties is 
iteratively minimized using various algorithms. 
A novel experimental method also holds promise 
to achieving quantitative PA mapping of chromo-
phore concentrations [16]. The approach combines 
“...photoacoustic 
imaging combines the 
advantages from optical 
imaging, namely a high 
vascularization-driven 
optical absorption 
contrast from cancer, and 
the advantages from 
ultrasound imaging, 
namely a high resolution 
and a large imaging 
depth.”
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PAs with acousto-optic modulation of light using 
focused ultrasound. Early work has shown that 
PA signals of absorbing insertions in a phantom 
at different depths can be fluence-corrected by 
this method to achieve an accuracy of 5% in 
 estimation of absorption coefficient.
Multimodality imaging
PA mammography can be combined with other 
imaging modalities to further improve specific-
ity. The application of radiofrequency (RF) or 
microwave excitations can also generate ultra-
sound in the breast. This method, called ther-
moacoustic (TA) tomography, was introduced 
by Kruger et al. [5]. The absorbed RF energy 
excites US pressure waves just as in PA. Since 
RF radiation can penetrate tens of centimeters 
tissues due to its long wavelength, TA tomog-
raphy is expected to provide larger imaging 
depths than PA. TA tomography can be easily 
integrated with PA tomography with the two 
modalities sharing the same US detection and 
image reconstruction. This combination when 
applied in breast imaging has the potential to 
further improve the imaging sensitivity at large 
depths. The group of Wang integrated both PA 
and TA tomography in a single system in 2008 
[17]. Furthermore, PA tomography can be com-
bined with US tomography, since they share the 
same US detection [18]. The combination of PA 
and US tomography will have additional clinical 
values compared with single PA modality. US 
reflection imaging provides the breast anatomy 
and maps the tissue changes in echogenicity. It 
is also expected that speed of sound (SOS) and 
acoustic attenuation (AA) mapping provides 
additional diagnostic value, since higher SOS 
and AA values are reported to be associated with 
tumor mass compared with normal breast tissue.
PA mammography systems with handheld 
probes
The abovementioned systems are dedicated imag-
ing systems where the subject lies on a bed, which 
is the patient–instrument interface. However, 
these systems are usually bulky and expensive, 
which require custom-made ultrasound detec-
tion systems. PA mammography systems could 
also be built around flexible hand-held probes, 
which could have application in diagnosis. 
A straightforward approach is to integrate a 
pulsed laser source to a commercial US array as 
reported by Kolkman et al. [19]. Compared to the 
above-discussed CT-based breast imagers, the 
use of commercial US arrays has distinct advan-
tages. First, the system integrating both PA and 
US imaging provides additional information to 
purely PA imaging. Second, PA mammogra-
phy performed simultaneously with a routinely 
used ultrasonography will pave the way for the 
acceptance of PA mammography by medical 
staff. Finally, the use of commercial US arrays 
will shorten the time for system development and 
thus reduce the system cost.
Contrast agents enhanced PA 
mammography
Most of current PA mammography systems 
are based on hemoglobin detection, utiliz-
ing endogenous chromophores. The detection 
of the extremely weak PA signals from small 
cancers deep inside the breast challenges the 
sensitivity of the imaging systems. Exogenous 
contrast agents can be used to greatly enhance 
the imaging contrast, and further allow cellular 
and molecular imaging for enhanced specificity 
of PA imaging [20].
Along with the continuous growth of the PA 
research community, more and more interest-
ing functions of PA imaging will be discovered 
and applied to breast imaging. The future roles 
of PA mammography in clinical practice will 
strongly depend on the outcome of clinical 
case studies. Sensitivity and specificity of the 
imagers need to be evaluated in comparison to 
x-ray mammography and MRI. With tremen-
dous promise, PA mammography could supple-
ment x-ray mammography for use as a diagnosis 
tool, or if possessing sufficient sensitivity and 
specificity, could potentially replace x-ray mam-
mography for breast cancer screening. We look 
forward to seeing the commercialization of PA 
mammography in the near future.
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